Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
By binding to BCL-2 protein, venetoclax inhibits the obstruction of apoptosis of···【more】
Release date：2024-08-13Recommended：250
Venetoclax is a small molecule drug approved in combination with azacitidine for···【more】
Release date：2024-08-13Recommended：238
Venetoclax is an oral targeted drug that can effectively inhibit the anti-apopto···【more】
Release date：2024-08-13Recommended：300
Venetoclax is a targeted drug used in the treatment of a variety of hematologic ···【more】
Release date：2024-08-13Recommended：254
Venetoclax is the only approved selective inhibitor of Bcl-2 in the world. By bi···【more】
Release date：2024-08-13Recommended：265
As a potent and selective oral inhibitor targeting FGFR subtypes 1/2/3, Pemigati···【more】
Release date：2024-08-13Recommended：180
Pemigatinib, brand name Damitan, is a potent and selective oral inhibitor agains···【more】
Release date：2024-08-13Recommended：172
Pemigatinibis a small molecule kinase inhibitor targeting the fibroblast growth ···【more】
Release date：2024-08-13Recommended：239
Pemigatinib is indicated for adult patients with advanced, metastatic, or unrese···【more】
Release date：2024-08-13Recommended：250
Pemigatinib is an innovative targeted therapy that provides a new treatment opti···【more】
Release date：2024-08-13Recommended：281
Pemigatinibis mainly used to treat specific diseases such as advanced or metasta···【more】
Release date：2024-08-13Recommended：271
Pemigatinib is used in adults to treat bile duct cancer that has spread to other···【more】
Release date：2024-08-13Recommended：235
